|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1050 Thomas Jefferson Street, NW |
Address2 | Seventh Floor |
| City | Washington |
State | DC |
Zip Code | 20007 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 39815-315
|
||||||||
|
6. House ID# 301710020
|
||||||||
| TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Curt Rich, Member |
Date | 01/13/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Education regarding the Department of Veterans Affairs Pharmaceutical Prime Vendor contract.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jordan |
Smith |
|
|
|
Ben |
McMakin |
|
|
|
Nancy |
McNally |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 3800, Promoting Health Information Technology Act
S. 1456, Federal Employees Electronic Personal Health Records Act of 2007
S. 631, Remote Monitoring Access Act of 2007
S. 2408, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
H.R. 4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
S. 628, Critical Access to Health Information Technology Act of 2007
S. 1814, Health Information Privacy and Security Act
S. 1915, Electronic Prescription Drug Act of 2007
S. 2029, Physician Payments Sunshine Act of 2007
H.R. 2991, Independent Health Record Trust Act of 2007
S. 1695, Biologics Price Competition and Innovation Act of 2007
S. 1693, Wired for Health Care Quality Act
H.R. 1368, Personalized Health Care Quality Act
S. 1783, Ten Steps to Transform Health Care in America Act
S. 321, Fostering Independence Through Technology Act of 2007
H.R. 6357, Protecting Records, Optimizing Treatment, and Easing Communication Through Healthcare Technology Act
H.R. 6179, Promoting Health Information Technology Act
H.R. 6898, Health-e Information Technology Act of 2008
S. 1456, The Federal Employees Electronic Personal Health Records Act of 2007
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Agnew |
|
|
|
Howard |
Feldman |
|
|
|
John |
Iani |
|
|
|
Ben |
McMakin |
|
|
|
Nancy |
McNally |
|
|
|
Jordan |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
S. 1544, Medicare Quality Enhancement Act of 2007
S. 1951, Fair Medicaid Drug Payment Act of 2007
H.R. 3700, Fair Medicaid Drug Payment Act of 2007
H.R. 2770, Legislation to ensure more appropriate payment amounts for drugs and biologics under Part B of the Medicare program by excluding customary prompt pay discounts.
H.R. 6331, Medicare Improvements for Patients and Providers
S. 3101, Medicare Improvements for Patients and Providers
S. 3118, Preserving Access to Medicare Act of 2008
S. 1954, Pharmacy Access Improvement (PhAIm) Act of 2007
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Agnew |
|
|
|
Howard |
Feldman |
|
|
|
John |
Iani |
|
|
|
Ben |
McMakin |
|
|
|
Nancy |
McNally |
|
|
|
Jordan |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007
H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007
S. 251, Pharmaceutical Market Access Act of 2007
S. 596, Safe Internet Pharmacy Act of 2007
H.R. 5839, Safeguarding America's Pharmaceuticals Act
S. 207, Combat Methamphetamine Enhancement Act of 2007
H.R. 971, Community Pharmacy Fairness Act of 2007
S. 885, Community Pharmacy Fairness Act of 2007
H.R. 3140, Saving Our Community Pharmacies Act of 2007
H.R. 3193, Access to Community Pharmacy Preservation Act of 2007
H.R. 780, Counterfeit Drug Prevention Act of 2007
S. 2085, Patient and Pharmacy Protection Act of 2007
H.R. 6353, Online Pharmacy Consumer Act
S. 1954, Pharmacy Access Improvement Act of 2007
H.R. 5629, Pathway for Biosimilars Act
H.R. 3610, Food and Drug Import Safety Act of 2007
H.R. 5619, Combat Methamphetamine Enhancement Act of 2008
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Agnew |
|
|
|
Howard |
Feldman |
|
|
|
John |
Iani |
|
|
|
Ben |
McMakin |
|
|
|
Nancy |
McNally |
|
|
|
Jordan |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Legislation regarding potential LIFO repeal.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Howard |
Feldman |
|
|
|
Nancy |
McNally |
|
|
|
Curt |
Rich |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIN
16. Specific lobbying issues
H.R. 1424, Emergency Economic Stabilization Act of 2008
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Nancy |
McNally |
|
|
|
Jordan |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
5 |
|
||||||
| 2 |
|
6 |
|
||||||
| 3 |
|
7 |
|
||||||
| 4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 3 | 5 |
| 2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 5 | 9 |
| 2 | 6 | 10 |
| 3 | 7 | 11 |
| 4 | 8 | 12 |